Actinium Pharmaceuticals, Inc.
ATNM
$1.29
-$0.105-7.55%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -4.70% | -21.32% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -40.44% | 1.47% | |||
| Operating Income | 40.44% | -1.47% | |||
| Income Before Tax | 42.50% | -1.89% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 42.50% | -1.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 42.50% | -1.89% | |||
| EBIT | 40.44% | -1.47% | |||
| EBITDA | 39.89% | -1.39% | |||
| EPS Basic | 42.73% | 1.27% | |||
| Normalized Basic EPS | 42.76% | 1.27% | |||
| EPS Diluted | 42.73% | 1.27% | |||
| Normalized Diluted EPS | 42.76% | 1.27% | |||
| Average Basic Shares Outstanding | 0.43% | 3.22% | |||
| Average Diluted Shares Outstanding | 0.43% | 3.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
